Projects per year
Fingerprint Dive into the research topics where Katrina Lappin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 5 Similar Profiles
Myelodysplastic Syndromes
Medicine & Life Sciences
Amino Acyl-tRNA Synthetases
Medicine & Life Sciences
Azaguanine
Medicine & Life Sciences
Acute Myeloid Leukemia
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Cell Line
Medicine & Life Sciences
Pediatrics
Medicine & Life Sciences
Apoptosis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2019 2019
- 1 Active
R2557CNR: Identifying Combination Therapies Targeting Apoptosis Pathways in Paediatric AML (CAuSAL study)
11/02/2019 → …
Project: Research
Research Output 2015 2019
Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability
Liberante, F. G., Lappin, K., Barros, E. M., Vohhodina, J., Grebien, F., Savage, K. I. & Mills, K. I., 25 Feb 2019, In : Scientific Reports. 9, 13 p., 2678.Research output: Contribution to journal › Article
Open Access
File
Amino Acyl-tRNA Synthetases
Azaguanine
Myelodysplastic Syndromes
Mutation
RNA Splicing
Identifying Combination Therapies Targeting Apoptosis Pathways in Pediatric Acute Myeloid Leukemia (CAuSAL Study)
Lappin, K., Matchett, K., Blayney, J. & Mills, K., 2018.Research output: Contribution to conference › Abstract
Acute Myeloid Leukemia
Pediatrics
Apoptosis
Cell Line
Therapeutics
Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy
Hay, J. F., Lappin, K., Liberante, F., Kettyle, L. M., Matchett, K. B., Thompson, A. & Mills, K. I., 01 Jul 2017, In : Oncotarget. 8, 40, p. 67891-67903 13 p.Research output: Contribution to journal › Article
Open Access
File
Histone Deacetylase Inhibitors
Hematologic Neoplasms
Therapeutics
Acetylation
Heterografts
Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromes
Palau, A., Garz, A. K., Diesch, J., Zwick, A., Malinverni, R., Valero, V., Lappin, K., Casquero, R., Lennartsson, A., Zuber, J., Navarro, T., Mills, K. I., Götze, K. S. & Buschbeck, M., 01 Dec 2017, In : Oncotarget. 8, 70, p. 115002-115017 16 p.Research output: Contribution to journal › Article
Open Access
File
Myelodysplastic Syndromes
Proteins
Epigenomics
Polycomb Repressive Complex 1
Polycomb Repressive Complex 2
The molecular and therapeutic relevance of SF3B1 in myelodysplastic syndrome
Lappin, K. M., Liberante, F. G., Savage, K. I. & Mills, K. I., 19 Apr 2015, In : British Journal of Haematology. 169, Supplement s1, p. 87 1 p.Research output: Contribution to journal › Meeting abstract
Activities 2018 2019
#teamkai
Ken Mills (Recipient), Katrina Lappin (Participant)18 Apr 2019
Activity: Other activity types › Hosting a delegation or group
Wendy Tarplee-Morris
Ken Mills (Host), Katrina Lappin (Host), Kyle Matchett (Host)31 Jul 2018
Activity: Hosting a visitor types › Hosting of external, non-academic visitor